Edgewise Therapeutics (EWTX)
NASDAQ:EWTX
US Market
Holding EWTX?
Track your performance easily

Edgewise Therapeutics (EWTX) Financial Statements

271 Followers

Edgewise Therapeutics Financial Overview

Edgewise Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.533; its P/E ratio is -12.44; Edgewise Therapeutics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -31.50M$ -34.75M$ -33.86M$ -25.71M$ -21.47M
EBITDA$ -27.79M$ -34.23M$ -33.33M--
Net Income Common Stockholders$ -31.50M$ -28.52M$ -30.14M$ -25.71M$ -21.47M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 511.75M$ 532.76M$ 318.39M$ 289.70M$ 309.93M
Total Assets$ 531.65M$ 553.81M$ 340.04M$ 311.36M$ 330.63M
Total Debt$ 4.99M$ 5.25M$ 5.41M$ 5.53M$ 5.64M
Net Debt$ -506.77M$ -527.51M$ -312.98M$ -284.17M$ -304.29M
Total Liabilities$ 21.17M$ 18.86M$ 21.20M$ 20.94M$ 19.17M
Stockholders Equity$ 510.46M$ 534.93M$ 318.83M$ 290.43M$ 311.46M
Cash Flow-
Free Cash Flow$ -26.32M$ -28.89M$ -26.99M--
Operating Cash Flow$ -26.10M$ -28.60M$ -26.83M$ -22.06M-
Investing Cash Flow$ 37.37M$ -268.31M$ 26.98M$ 23.42M-
Financing Cash Flow$ 1.95M$ 241.07M$ 52.99M$ -211.00K-
Currency in USD

Edgewise Therapeutics Earnings and Revenue History

Edgewise Therapeutics Debt to Assets

Edgewise Therapeutics Cash Flow

Edgewise Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis